Direct-to-Patient Market Report 2021-2031: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Direct-to-Patient Healthcare Model is Gaining Tractions Globally
Direct-to-Patient programmes are being considered not just as a cost-effective alternative to the traditional paradigm, but also as an incentive to improve patient enrolment, shorten trial periods, and reduce total costs. Direct-to-Patient programmes will be a very useful tool for a more robust clinical trial provided the solution is deemed a good fit for the study and proper due diligence is carried out.

In the future years, technological advancements, particularly enhanced measuring technologies, will continue to improve the approach, enhancing the patient experience and providing stakeholders with a clearer perspective of the supply chain. With this in mind, advertisers should start looking into whether or not this strategy is viable for future trials.

The Integration of DTP with the hospitals, clinics and medical university opens up a wider range of opportunities
The integration of the DTP into hospitals, clinics and medical universities offers companies a broader range of opportunities to receive on-site further training in clinical trials. Many seminars are offered free of charge to employees, such as medicines training, drug equipment, good clinical practice, design of studies, pharmacovigilance, and clinical trial analysis and interpretation.

You need to discover how this will impact the direct-to-patient market today, and over the next 10 years:
  • Our 691-page report provides 402 tables and 356 charts/graphs exclusively to you.
  • The report highlights key lucrative areas in the industry so you can target them – NOW.
  • Contains in-depth analysis of global, regional and national sales and growth
  • Highlights for you the key successful trends, changes and revenue projections made by your competitors

This report tells you TODAY how the direct-to-patient market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.
This report includes data analysis and invaluable insight into how COVID-19 will affect your industry. Access this report today.

Forecasts to 2031 and other analyses reveal the commercial prospects
  • In addition to revenue forecasting to 2031, our new study provides you with recent results, growth rates, and market shares.
  • You find original analyses, with business outlooks and developments.
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, the impact of rising direct-to-patient prices and recent developments.
This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, V, L, W and U are discussed in this report.

Global Direct-to-Patient Market Breakdown by Type (COVID Impact Analysis)
  • Direct-to-Patient Marketing
  • Direct-to-Patient Health Services
  • Direct-to-Patient Clinical Trials
  • Direct-to-Patient Logistics

Global Direct-to-Patient Market Breakdown by Direct-to-Patient Marketing (COVID Impact Analysis)
  • DTC Prescribed Drug Advertising
  • Disease Awareness Campaigns
  • Brand Promotion
  • Healthcare Services Promotion
  • Laboratory Testing Promotion
  • Other Direct-to-Patient Marketing

Global Direct-to-Patient Market Breakdown by Direct-to-Patient Health Services (COVID Impact Analysis)
  • Tele Consultation
  • Drug Prescription
  • Medical Call Centers
  • Telesampling
  • Online Services

Global Direct-to-Patient Market Breakdown by Clinical Trials (COVID Impact Analysis)
  • Tele Health Screening
  • Investigational Medicinal Product (IMP)
  • Patient Support Systems
  • Other Clinical Trial Services

Global Direct-to-Patient Market Breakdown by Logistics (COVID Impact Analysis)
  • Prescribed Medicine Delivery
  • Pre-Clinical Supplies
  • Clinical Trial Supplies
  • Home Trial Support
  • Test Samples Collection
  • Rest All CSO Services

Global Direct-to-Patient Market Breakdown by Therapeutics (COVID Impact Analysis)
  • Cardiovascular Disease
  • Respiratory Diseases
  • Oncology
  • Infectious Diseases
  • Dermatology
  • Other Therapeutics

Global Direct-to-Patient Market Breakdown by Model (COVID Impact Analysis)
  • Investigator Site Pharmacy
  • Central Pharmacy
  • Depot Distribution to Local Pharmacy
  • Direct from Patient
  • Other DtP Models

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 4 regional and 20 leading national markets:

North America Direct-to-Patient Market, 2021 to 2031 Market Outlook
  • U.S. Direct-to-Patient Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
  • Canada Direct-to-Patient Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
  • Mexico Direct-to-Patient Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
Europe Direct-to-Patient Market, 2021 to 2031 Market Outlook
  • Germany Direct-to-Patient Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
  • Spain Direct-to-Patient Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
  • United Kingdom Direct-to-Patient Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
  • France Direct-to-Patient Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
  • Italy Direct-to-Patient Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
  • Rest of Europe Direct-to-Patient Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
Asia Pacific Direct-to-Patient Market, 2021 to 2031 Market Outlook
  • China Direct-to-Patient Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
  • Japan Direct-to-Patient Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
  • India Direct-to-Patient Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
  • Australia Direct-to-Patient Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
  • South Korea Direct-to-Patient Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
  • Rest of Asia Pacific Direct-to-Patient Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
LAMEA Direct-to-Patient Market, 2021 to 2031 Market Outlook
  • Brazil Direct-to-Patient Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
  • Turkey Direct-to-Patient Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
  • Saudi Arabia Direct-to-Patient Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
  • South Africa Direct-to-Patient Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
  • UAE Direct-to-Patient Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
  • Rest of Latin America, Middle East and Africa Direct-to-Patient Market, 2021 to 2031 Market Forecast & COVID Impact Analysis